News

The new rotavirus vaccine is expected to be made available at a cost of around $1 per dose, allowing poor countries to easily vaccinate their children against the

The patent application ‘Alpha Emitting Constructs and Uses Thereof’ is licensed by Actinium from Memorial Sloan Kettering Cancer Center. Actinium CMO Dragan Cicic said the decision is important

BioGaia ProTectis baby drops and the BioGaia ProTectis tablets contain BioGaia’s patented and researched probiotic strain Lactobacillus reuteri Protectis. BioGaia Gastrus is a new product that is currently

Reprints Desk’s Sunshine ePrints solution simplifies Sunshine Act compliance for the use of medical ePrints for sales, marketing and medical affairs. The solution records the delivery of each

As per the terms of the license and development agreement, Toyama will have exclusive rights to develop and commercialize solithromycin in Japan. Cempra will receive an upfront payment

The first fully human monoclonal antibody Sarilumab is directed against the IL-6 receptor and delivered by subcutaneous injection every other week. Regeneron Laboratories president and Regeneron chief scientific

The CMC’s CHEF1 high-productivity expression plasmid will be leveraged for the cell line development to optimize cell growth, and consistent, high-level protein expression in a rapid time frame.

IGDRASOL had earlier acquired exclusive US distribution rights to Cynviloq, which is a next-generation, branded, micellar diblock copolymeric paclitaxel formulation currently approved and marketed in several countries, including

The entity group that includes affiliates of Greenspring Associates, QIC Global Private Equity, and Thomas McNerney & Partners was formed to acquire the AmerisourceBergen’s contract packaging business. The